Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardian Pharmacy Services (GRDN) Net Income towards Common Stockholders (2023 - 2025)

Historic Net Income towards Common Stockholders for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $9.6 million.

  • Guardian Pharmacy Services' Net Income towards Common Stockholders rose 10906.57% to $9.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.5 million, marking a year-over-year increase of 15787.02%. This contributed to the annual value of -$71.0 million for FY2024, which is 28831.65% down from last year.
  • Guardian Pharmacy Services' Net Income towards Common Stockholders amounted to $9.6 million in Q3 2025, which was up 10906.57% from $8.8 million recorded in Q2 2025.
  • In the past 5 years, Guardian Pharmacy Services' Net Income towards Common Stockholders registered a high of $15.8 million during Q2 2024, and its lowest value of -$105.8 million during Q3 2024.
  • In the last 3 years, Guardian Pharmacy Services' Net Income towards Common Stockholders had a median value of $9.3 million in 2025 and averaged -$4.0 million.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first crashed by 141275.2% in 2024, then skyrocketed by 10906.57% in 2025.
  • Quarter analysis of 3 years shows Guardian Pharmacy Services' Net Income towards Common Stockholders stood at $14.6 million in 2023, then fell by 18.67% to $11.8 million in 2024, then decreased by 18.98% to $9.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at $9.6 million for Q3 2025, versus $8.8 million for Q2 2025 and $9.3 million for Q1 2025.